Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients

Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins were measured in longitudinal plasma samples collected from 13 participants who received two doses of mRNA-1273 vaccine. Eleven of 13 participants showed detectable levels of SARS-CoV-2 protein as early as day 1 after first vaccin...

Full description

Bibliographic Details
Main Authors: Baden, L.R (Author), Cheng, C.-A (Author), Desjardins, M. (Author), Li, X. (Author), Novack, L. (Author), Ogata, A.F (Author), Powell, M. (Author), Senussi, Y. (Author), Sherman, A.C (Author), Von, S. (Author), Walt, D.R (Author)
Format: Article
Language:English
Published: Oxford University Press 2022
Subjects:
2019-nCoV Vaccine mRNA-1273
adult
Antibodies, Viral
antibody production
antigen
Article
blood sampling
clinical article
clinical trial
controlled study
coronavirus disease 2019
coronavirus nucleocapsid protein
coronavirus spike glycoprotein
COVID-19
COVID-19 Vaccines
disease severity
elasomeran
genetics
health care personnel
human
human tissue
Humans
immune responses
immunoassay
immunoglobulin A
Immunoglobulin A
immunoglobulin blood level
immunoglobulin G
immunoglobulin M
limit of detection
mrna 1273
mRNA vaccine
pilot study
prevention and control
protein blood level
receptor binding
RNA translation
SARS-CoV-2
SARS-CoV-2 antigens
Severe acute respiratory syndrome coronavirus 2
spike
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
virus antibody
virus neutralization
virus nucleocapsid
virus spike
virus spike protein
young adult
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items